Literature DB >> 12644776

Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk.

Stacy K Carmichael1, Suzanne Bennett Johnson, Amy Baughcum, Kerri North, Diane Hopkins, Margaret G Dukes, Jin-Xiong She, Desmond A Schatz.   

Abstract

PURPOSE: To assess accuracy of mothers' understanding of their newborns' genetic risk for type 1 diabetes and to identify predictors of the comprehension and retention of genetic information.
METHODS: Mothers of 435 newborns genetically screened at birth were informed of the infant's risk for type 1 diabetes using a standard script that provided both categorical and numerical risk information. The mothers' comprehension and retention of this information were assessed by structured interview on two occasions, approximately 3.6 weeks and approximately 3.9 months postnotification.
RESULTS: At the initial interview, 73.1% of mothers gave a correct estimate of their child's genetic risk, 3.2% overestimated risk, 13.3% underestimated risk, and 10.3% could not recall risk at all. At the follow-up interview, fewer mothers (61.9%) correctly estimated their child's risk and more mothers (24.4%) underestimated their child's risk. Maternal accuracy was associated with maternal education, ethnic minority status, infant risk status, maternal ability to spontaneously recall both categorical and numerical risk estimates, and length of time since risk notification. Underestimation of risk was associated with maternal education, family history of diabetes, time since risk notification, and maternal anxiety about the baby's risk.
CONCLUSION: The accuracy of mothers' recall of infant risk declines over time, with an increasing number of mothers underestimating the infant's risk. Effective risk communication strategies need to be developed and incorporated into genetic screening programs.

Entities:  

Mesh:

Year:  2003        PMID: 12644776     DOI: 10.1097/01.GIM.0000055196.67008.1B

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  18 in total

1.  Newborn screening in North America.

Authors:  Bradford L Therrell; John Adams
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

Review 2.  Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

Authors:  Anne Julie Overgaard; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 3.  Psychological impact of screening and prediction in type 1 diabetes.

Authors:  Suzanne Bennett Johnson
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

4.  Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes.

Authors:  Nicola J Kerruish; Dione M Healey; Andrew R Gray
Journal:  Eur J Hum Genet       Date:  2017-01-25       Impact factor: 4.246

5.  An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age.

Authors:  I Vermeulen; I Weets; O Costa; M Asanghanwa; K Verhaeghen; K Decochez; J Ruige; K Casteels; J Wenzlau; J C Hutton; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2011-11-18       Impact factor: 10.122

6.  Biomarkers for type 1 diabetes.

Authors:  Sharad Purohit; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2008-02-29

Review 7.  The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice.

Authors:  Jeffrey W Kleinberger; Kristin A Maloney; Toni I Pollin
Journal:  Am J Perinatol       Date:  2016-08-29       Impact factor: 1.862

8.  Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.

Authors:  Sharad Purohit; Ashok Sharma; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Tao Yang; Jin-Xiong She
Journal:  J Clin Endocrinol Metab       Date:  2015-07-09       Impact factor: 5.958

9.  Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications.

Authors:  Shangsu Lu; Sharad Purohit; Ashok Sharma; Wenbo Zhi; Mingfang He; Yiqian Wang; Chao-Jun Li; Jin-Xiong She
Journal:  Int J Clin Exp Med       Date:  2012-06-10

10.  Predicting Later Study Withdrawal in Participants Active in a Longitudinal Birth Cohort Study for 1 Year: The TEDDY Study.

Authors:  Suzanne Bennett Johnson; Kristian F Lynch; Judith Baxter; Barbro Lernmark; Roswith Roth; Tuula Simell; Laura Smith
Journal:  J Pediatr Psychol       Date:  2015-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.